Salesforce, Inc.
CRM · NYSE · Technology
+$14.93 today
- Mkt cap $156.51B
- P/E 22.1
- Day $180.02 – $194.14
Confidence
High conviction
The read
Salesforce shares rally 8.5% post-earnings despite no EPS actuals; strong valuation and growth underpin optimism
Salesforce reported Q1 earnings with no EPS actuals available yet, shares rose 8.5% to $191.10. Analysts maintain a buy consensus with a $264 target, citing solid growth and attractive valuation. The company plans a $6 billion UK investment and $850 million in generative AI startups, expecting 10.9% revenue and 5% earnings growth this year. Market reaction reflects confidence despite sector weakness.
Confidence note: Strong analyst consensus, clear valuation discount, and concrete growth targets support confident interpretation despite missing EPS actuals.
What happened
Earnings print
Guidance
Price reaction
Street narrative
So what
What changed
What the market is pricing
Fundamental takeaway
Next 30–90 days
Sustained revenue and earnings growth with successful AI investments drive multiple expansion.
- boltNext quarterly revenue growth above 11%
- boltPositive updates on UK investment progress
Growth continues at moderate pace with stable valuation; shares trade sideways to modestly higher.
- boltRevenue growth around 10% next quarter
- boltNo major changes in guidance or analyst ratings
Sector weakness and execution risks pressure shares despite solid fundamentals, causing multiple contraction.
- boltEarnings or revenue miss next quarter
- boltDelay or cutback in UK or AI investments
What to do
If you hold it
If you're watching
Keep on your radar
- Next quarterly revenue and EPS growth rates (due ~August 2026)
- Progress updates on $6B UK investment and $850M AI startup deployments
- Analyst rating changes and target price revisions
- Sector software market trends and selloff intensity